Compare Sterling Biotech with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs FRESENIUS KABI ONCO. - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH FRESENIUS KABI ONCO. STERLING BIOTECH/
FRESENIUS KABI ONCO.
 
P/E (TTM) x -0.4 22.1 - View Chart
P/BV x 0.0 3.1 0.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
FRESENIUS KABI ONCO.
Mar-13
STERLING BIOTECH/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs11176 6.0%   
Low Rs379 4.3%   
Sales per share (Unadj.) Rs26.837.7 71.1%  
Earnings per share (Unadj.) Rs-15.05.1 -293.7%  
Cash flow per share (Unadj.) Rs-5.56.7 -81.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.942.5 129.0%  
Shares outstanding (eoy) m267.87158.23 169.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 7.7%   
Avg P/E ratio x-0.525.0 -1.9%  
P/CF ratio (eoy) x-1.318.9 -6.7%  
Price / Book Value ratio x0.13.0 4.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,86220,135 9.2%   
No. of employees `0001.41.2 117.5%   
Total wages/salary Rs m547703 77.8%   
Avg. sales/employee Rs Th5,303.35,176.2 102.5%   
Avg. wages/employee Rs Th403.8610.4 66.2%   
Avg. net profit/employee Rs Th-2,959.0699.6 -423.0%   
INCOME DATA
Net Sales Rs m7,1815,963 120.4%  
Other income Rs m4318 236.7%   
Total revenues Rs m7,2235,981 120.8%   
Gross profit Rs m9471,430 66.2%  
Depreciation Rs m2,543258 986.1%   
Interest Rs m4,377-26 -16,835.0%   
Profit before tax Rs m-5,9311,216 -487.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m-1,924342 -562.3%   
Profit after tax Rs m-4,007806 -497.1%  
Gross profit margin %13.224.0 55.0%  
Effective tax rate %32.428.1 115.3%   
Net profit margin %-55.813.5 -412.8%  
BALANCE SHEET DATA
Current assets Rs m14,3355,102 281.0%   
Current liabilities Rs m49,8092,385 2,088.1%   
Net working cap to sales %-494.045.6 -1,084.6%  
Current ratio x0.32.1 13.5%  
Inventory Days Days403150 268.9%  
Debtors Days Days171113 150.6%  
Net fixed assets Rs m55,4325,148 1,076.8%   
Share capital Rs m268158 169.3%   
"Free" reserves Rs m13,9356,556 212.6%   
Net worth Rs m14,7016,732 218.4%   
Long term debt Rs m9,478952 995.4%   
Total assets Rs m73,98810,388 712.2%  
Interest coverage x-0.4-45.8 0.8%   
Debt to equity ratio x0.60.1 455.8%  
Sales to assets ratio x0.10.6 16.9%   
Return on assets %0.57.5 6.7%  
Return on equity %-27.312.0 -227.6%  
Return on capital %-6.414.6 -44.0%  
Exports to sales %25.974.5 34.8%   
Imports to sales %0.224.8 0.7%   
Exports (fob) Rs m1,8604,441 41.9%   
Imports (cif) Rs m121,477 0.8%   
Fx inflow Rs m1,8605,298 35.1%   
Fx outflow Rs m251,772 1.4%   
Net fx Rs m1,8353,525 52.0%   
CASH FLOW
From Operations Rs m1,7191,274 134.9%  
From Investments Rs m-3,148-1,204 261.4%  
From Financial Activity Rs m1,426-196 -727.2%  
Net Cashflow Rs m-3-126 2.7%  

Share Holding

Indian Promoters % 33.9 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 9.9 9.6 103.1%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 9.1 431.9%  
Shareholders   21,482 42,599 50.4%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS